The journal retracts the article, “GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation” [1], cited above. This evidence concerns the gene GSK3B and melanoma.